In a potential game changer for the treatment of superbugs, a new class of antibiotics was developed that […]

Company has reported strong momentum among the early-stage businesses it invested in last year

Research concerning candidate VLA15 has been discontinued across certain trial sites

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Psychostimulants interacting with the dopamine transporter are found in the therapy of neuro-psychiatric disorders, such as ADHD or […]

First subject dosed with company’s SPL028 – a proprietary deuterated DMT candidate